Skip to main content
HR 7917 116th Congress House Taxation Appropriations Business expenses Cardiovascular and respiratory health Corporate finance and management Disability assistance Drug therapy Emergency medical services and trauma care Government trust funds Health promotion and preventive care Health technology, devices, supplies Income tax credits Income tax deductions Infectious and parasitic diseases Medical research Medical tests and diagnostic methods Medicare Prescription drugs Research and development Social security and elderly assistance

IGNITE American Innovation Act

Introduced: October 20, 2020 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2020
Referred to the Subcommittee on Select Revenue Measures.
Jul 31, 2020
Referred to the House Committee on Ways and Means.
Jul 31, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Innovation and Growth Now by Investing in Tomorrow's Enterprises Act or the IGNITE American Innovation Act

This bill allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 (i.e., coronavirus disease 2019) research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net operating loss carryovers arising during 2015 through 2021.

The bill allows an increased research tax credit for COVID-19 research expenditures paid or incurred on or after February 15, 2020, and before January 1, 2022.

What's happening now July 31, 2020

Referred to the Subcommittee on Select Revenue Measures.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Republican 1
Bucshon, Larry
· Oct 20, 2020
Stewart, Chris
· Sep 29, 2020
 R
Curtis, John R.
Utah · Aug 14, 2020
Walorski, Jackie
· Jul 31, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7917: IGNITE American Innovation Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-7917/
MLA
"H.R. 7917: IGNITE American Innovation Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-7917/.
Bluebook (legal)
H.R. 7917, 116th Cong. (2026), https://openamerica.io/bill/116-HR-7917/.
Markdown link
[H.R. 7917: IGNITE American Innovation Act](https://openamerica.io/bill/116-HR-7917/)
Report a problem